Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Subashchandrabose Chinnathambi obtained his Ph.D. in Biochemistry from Max Planck Institute for Structural Molecular Biology (MPGASMB), Hamburg, Germany in 2011. He has examined the Influence of Phosphorylation on the Pathological Conformation of Human Microtubule-Associated Protein Tau in Alzheimer’s disease. His post-doctoral training at the German Center for Neurodegeneration Disease (DZNE)–Bonn and Max Planck Institute for Neurobiological Research-Cologne, Germany, studied the role of rare MAPT (p. A152T mutant) mutation increases the pathological conformation and physiological properties of Tau (axonal protein) in Alzheimer’s patient. After the post-doctoral stint he joined as a Scientist at the Biochemical Sciences Division, National Chemical Laboratory (CSIR-NCL). In last three years, he established a neurobiology research group at CSIR-NCL; he is currently focusing on signaling cascades and post-translational modifications of Tau (Alzheimer’s) and Alpha Synuclein (Parkinson’s) disease. He has expertise in the area of neurochemistry and especially on Alzheimer’s disease
Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.